Abstract

Background: Metabolic acidosis in patients with chronic kidney disease (CKD) is a common complication. A bicarbonate concentration in venous blood (V-HCO3−) is a key index for diagnosis and treatment initiation. The aim of our study is to evaluate usability of acid–base balance parameters of in blood taken simultaneously from peripheral artery and the vein. Methods: A total of 49 patients (median age 66 years [interquartile range IQR 45–75]), with CKD stage G4 or G5 were enrolled in this cross-sectional study. All patients were qualified for arteriovenous fistula creation in pre-dialysis period. The samples were taken during surgery, directly after dissection, and evaluated in a point of care testing analyzer. The arteriovenous difference in bicarbonate levels (Δ-HCO3−) was calculated. According to glomerular filtration rate (eGFR) the group was divided into Group A eGFR ≥ 10 mL/min/1.73 m2) and Group B eGFR < 10 mL/min/1.73 m2). Results: In Group A Δ-HCO3− was significantly higher compared to Group B. No such differences were observed in the case of V-HCO3−. Δ-HCO3− positively correlated with eGFR. The discriminative power of Δ-HCO3− for predicting eGFR < 10 mL/min/1.73 m2 was 0.72 (95% confidence interval [CI] = 0.551–0.88; p = 0.01) which provided 67% sensitivity and 75% specificity. The best cut-off was 0.5 mmol/L. Conclusions: The Δ-HCO3− lower than 0.5 mmol/L may be used as predictor of exhaust buffer capacity. The value of this tool should be tested in larger population.

Highlights

  • Metabolic acidosis (MA) is a common disorder in patients with chronic kidney disease (CKD)

  • The indicators of kidney function, i.e., serum urea, creatinine and calculated eGFR, significantly correlated with several acide-base balance parameters (Table 3)

  • We found that the difference in bicarbonate concentration, between the artery and the vein (∆-HCO3 − ), decreases according to the progression of chronic kidney disease

Read more

Summary

Introduction

Metabolic acidosis (MA) is a common disorder in patients with chronic kidney disease (CKD). The major complications of the metabolic acidosis in CKD include increased muscle protein degradation, with muscle wasting [1], stimulation of inflammation, reduced albumin synthesis [2], hypertension [3], bone disease [4], progression of CKD [5], and an increase in mortality [4]. Venous blood is usually used to assess acid-base disorders in CKD patients [6,7]. Much more information can be drawn when both arterial and venous samples are taken at the same time and used for evaluation. Simultaneous venous and arterial blood collection is technically difficult, may lead to complications, such diagnostics is not a standard approach.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call